Publications by authors named "Jonathan Edelman"

Claim this Profile
S
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials.
Nhân Thị Hồ, Steven G Hughes, Van Thanh Ta, Lân Trọng Phan, Quyết Đỗ, Jonathan M Edelman

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting Clinical Care: SOFA on FHIR.
Margaux Gatrio, Ariane Morassi Sasso, Julian Sass, Prof Erwin Böttinger, Jonathan Antonio Edelman

AMIA Jt Summits Transl Sci Proc· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial.
Brandon J Essink, Marten Heeringa, Robert J Jeanfreau, Daniel Finn, Vince Matassa, Jonathan Edelman

Pediatrics· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Cohort Study on Pregnancy Outcomes of Persons Immunized with a Seasonal Quadrivalent Inactivated Influenza Vaccine during Pregnancy.
Christopher Robinson, Janine Oberye, Josephine van Boxmeer, Jessica D Albano, Hugh Tilson, Jonathan Edelman

Vaccines (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Pregnant Persons Immunized with a Cell-Based Quadrivalent Inactivated Influenza Vaccine: A Prospective Observational Cohort Study.
Christopher Robinson, Josephine Van Boxmeer, Hugh Tilson, Anthony Scialli, John A Vanchiere, Jonathan Edelman

Vaccines (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
StudyU: A Platform for Designing and Conducting Innovative Digital N-of-1 Trials.
Stefan Konigorski, Sarah Wernicke, Tamara Slosarek, Alexander M Zenner, Nils Strelow, Jonathan A Edelman

J Med Internet Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
Seth Toback, Eva Galiza, Catherine Cosgrove, James Galloway, Anna L Goodman, Jonathan Edelman

Lancet Respir Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children.
Terence Nolan, Alexandre C Fortanier, Brett Leav, Airi Põder, Lulu C Bravo, Jonathan M Edelman

N Engl J Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.
Sten Rüdiger, Stefan Konigorski, Alexander Rakowski, Jonathan Antonio Edelman, Detlef Zernick

Proc Natl Acad Sci U S A· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.
Jiří Beran, Humberto Reynales, Airi Poder, Charles Y Yu, Punnee Pitisuttithum, Jonathan Edelman

Lancet Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults.
Brandon Essink, Carlos Fierro, Jeffrey Rosen, Amparo L Figueroa, Bin Zhang, Jonathan Edelman

Vaccine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients.
Paula Busse, James Baker, Inmaculada Martinez-Saguer, Jonathan A Bernstein, Timothy Craig, Jonathan Edelman

J Allergy Clin Immunol Pract· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59 months of age: A phase 3, randomized, noninferiority study.
Victoria A Statler, Frank R Albano, Jolanta Airey, Daphne C Sawlwin, Alison Graves Jones, Jonathan Edelman

Vaccine· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.
Michael A Tortorici, James A Rogers, Oliver Vit, Martin Bexon, Robert A Sandhaus, Jonathan M Edelman

Br J Clin Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
Marc A Riedl, Anette Bygum, William Lumry, Markus Magerl, Jonathan A Bernstein, Jonathan Edelman

J Allergy Clin Immunol Pract· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.
Ingemar S J Merkies, John-Philip Lawo, Jonathan M Edelman, Jan L De Bleecker, Claudia Sommer

J Peripher Nerv Syst· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.
James Fox, Arthur B Vegh, Inmaculada Martinez-Saguer, Walter A Wuillemin, Jonathan Edelman

Allergy Asthma Proc· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
Hilary Longhurst, Marco Cicardi, Timothy Craig, Konrad Bork, Clive Grattan, Jonathan Edelman

N Engl J Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema.
Timothy Craig, Ralph Shapiro, Arthur Vegh, James W Baker, Jonathan A Bernstein, Jonathan Edelman

Allergy Rhinol (Providence)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry.
Markus Magerl, Michael Frank, William Lumry, Jonathan Bernstein, Paula Busse, Jonathan Edelman

Ann Allergy Asthma Immunol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
Noel G McElvaney, Jonathan Burdon, Mark Holmes, Allan Glanville, Peter A B Wark, Jonathan M Edelman

Lancet Respir Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert (C1-INH) Registry.
Anette Bygum, Inmaculada Martinez-Saguer, Murat Bas, Jeffrey Rosch, Jonathan Edelman

Drugs Aging· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.
Henriette Farkas, Lilian Varga, Dumitru Moldovan, Krystyna Obtulowicz, Todor Shirov, Jonathan Edelman

Ann Allergy Asthma Immunol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials.
Shuren Ma, Yong Y Lin, Jerome O Cantor, Kenneth R Chapman, Robert A Sandhaus, Jonathan M Edelman

Chronic Obstr Pulm Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
Sabine Häussermann, Cornelis Winnips, Jonathan Edelman, Dominik Kappeler, Christiane Herpich

J Aerosol Med Pulm Drug Deliv· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis